About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Fentanyl (transdermal patches, solution for injection - nationally authorised product only)
- Procedure number
- PSUSA/00001370/202104
- Regulatory outcome
- Variation
Documents
Fentanyl (transdermal patches, solution for injection - nationally authorised product only) : List of nationally authorised medicinal products - PSUSA/00001370/202104
English (EN) (310.82 KB - PDF)
Fentanyl (transdermal patches, solution for injection....) - CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001370/202104
English (EN) (215.41 KB - PDF)
български (BG) (236.63 KB - PDF)
español (ES) (177.54 KB - PDF)
čeština (CS) (224.68 KB - PDF)
dansk (DA) (49.59 KB - PDF)
Deutsch (DE) (240.61 KB - PDF)
eesti keel (ET) (213.86 KB - PDF)
ελληνικά (EL) (209.71 KB - PDF)
français (FR) (227.04 KB - PDF)
hrvatski (HR) (214.06 KB - PDF)
íslenska (IS) (42.06 KB - PDF)
italiano (IT) (202.33 KB - PDF)
latviešu valoda (LV) (229.23 KB - PDF)
lietuvių kalba (LT) (219.9 KB - PDF)
magyar (HU) (223.22 KB - PDF)
Malti (MT) (233.64 KB - PDF)
Nederlands (NL) (185.23 KB - PDF)
norsk (NO) (45.02 KB - PDF)
polski (PL) (214.03 KB - PDF)
português (PT) (42.96 KB - PDF)
română (RO) (214.59 KB - PDF)
slovenčina (SK) (220.72 KB - PDF)
slovenščina (SL) (215.2 KB - PDF)
Suomi (FI) (54.37 KB - PDF)
svenska (SV) (45.27 KB - PDF)